Davis's Lab & Diagnostic Tests
Toxoplasma Testing
To view the entire topic, please sign in or purchase a subscription.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
Synonym/Acronym:
Toxoplasmosis serology, toxoplasmosis titer; may be requested as part of TORCH panel.
Rationale
To assess for a past or present toxoplasmosis infection and to assess for the presence of antibodies.
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
Method: Chemiluminescent immunoassay.
| IgM and IgG | Interpretation | |
|---|---|---|
| Negative | 0.89 index or less | No significant level of detectable antibody |
| Indeterminate | 0.9–1 index | Equivocal results; retest in 10–14 days |
| Positive | 1.1 index or greater | Antibody detected; indicative of recent immunization, current or recent infection |
Critical Findings and Potential Interventions
N/A
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Synonym/Acronym:
Toxoplasmosis serology, toxoplasmosis titer; may be requested as part of TORCH panel.
Rationale
To assess for a past or present toxoplasmosis infection and to assess for the presence of antibodies.
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
Method: Chemiluminescent immunoassay.
| IgM and IgG | Interpretation | |
|---|---|---|
| Negative | 0.89 index or less | No significant level of detectable antibody |
| Indeterminate | 0.9–1 index | Equivocal results; retest in 10–14 days |
| Positive | 1.1 index or greater | Antibody detected; indicative of recent immunization, current or recent infection |
Critical Findings and Potential Interventions
N/A
There's more to see -- the rest of this entry is available only to subscribers.